JPRN-UMIN000040630已完成未知
Pharmacokinetics of asparaginase in patients with acute lymphoblastic leukemia: prospective observational study. - JCCG ALL-ASP19
Japan Children's Cancer Study Group(JCCG)0 个研究点目标入组 110 人开始时间: 2020年6月2日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 110
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 40years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Judged to be inappropriate for registration by investigators
研究者
相似试验
已完成
不适用
Clinical evaluation of Asparagine Synthetase (ASNS) Level in Leukemia/ Lymphoma Cells by Monoclonal Antibodieseukemia/LymphomaJPRN-UMIN000012119Aichi Medical University30
进行中（未招募）
不适用
Efficacy and safety of recombinant asparaginase in infants (< 1 year) with previously untreated acute lymphoblastic leukaemia - Phase II Clinical Trial - - Efficacy and safety of recombinant asparaginase in infants with previously untreated AAcute lymphoblastic leukaemia (ALL) is a clonal disease resulting from genetic mutations and transformation of a single early progenitor lymphoid cell. Uncontrolled expansion of leukaemic blasts in the bone marrow leads to suppression of normal haematopoiesis as well as disseminated infiltration of organs and release of blasts into periphal blood.MedDRA version: 9.1Level: LLTClassification code 10000844Term: Acute lymphoblastic leukaemiaEUCTR2008-006300-27-DEmedac Gesellschaft für klinische Spezialpräparate mbH12
进行中（未招募）
不适用
Efficacy and safety of recombinant asparaginase in infants (< 1 year) with previously untreated acute lymphoblastic leukaemia - Phase II Clinical Trial - - Efficacy and safety of recombinant asparaginase in infants with previously untreated AEUCTR2008-006300-27-NLmedac Gesellschaft für klinische Spezialpräparate mbH12
已完成
2 期
Efficacy and safety of recombinant asparaginase in infants ( < 1 year) with previously untreated acute lymphoblastic leukemia, a phase II clinical trialacute lymphoblastic leukemia in infants10024324NL-OMON33689Medac6
已完成
不适用
A pilot study of L-asparaginase monotherapy for Epstein-Barr virus positive T or NK cell lymphoproliferative disease (Chronic active Epstein-Barr virus infection)Epstein-Barr virus positive T or NK cell lymphoproliferative disease (Chronic active Epstein-Barr virus infection)JPRN-UMIN000003498Tokyo Medical and Dental University School of Medicine, Department of Hematology5